Recent studies have suggested that HDAC5 and HDAC9 are significantly upregulated in high-risk medulloblastoma in comparison with low-risk medulloblastoma and be associated with poor survival 6.It also has been reported that HDAC2 expression is significantly associated with CRC progression 7. This evidence concerns the gene HDAC9 and medulloblastoma.